- Current report filing (8-K)
July 16 2009 - 5:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities
Exchange Act of 1934
Date of Report
(Date of earliest event reported): July 16, 2009
BIOPURE CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
DELAWARE
|
|
000-15167
|
|
04-2836871
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
11 HURLEY STREET
CAMBRIDGE, MA 02141
(Address of principal executive offices and zip code)
(617) 234-6500
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(d))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
ITEM 1.03.
|
Bankruptcy or Receivership
|
On July 16, 2009,
Biopure Corporation (the Company) filed a voluntary petition for relief (the Bankruptcy Filing) under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Massachusetts
(the Bankruptcy Court). The Company will continue to operate its business and manage its properties as debtor in possession under the jurisdiction of the Bankruptcy Court and in accordance with the applicable provisions of the Bankruptcy
Code and orders of the Bankruptcy Court.
The Companys Chapter 11 case is administered by the Bankruptcy Court as Case
No. 09-16725-FJB.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
BIOPURE CORPORATION
|
|
|
|
|
Date: July 16, 2009
|
|
|
|
By:
|
|
/s/ Zafiris G. Zafirelis
|
|
|
|
|
|
|
Zafiris G. Zafirelis
|
|
|
|
|
|
|
President and Chief Financial Officer
|
Biopure (MM) (NASDAQ:BPUR)
Historical Stock Chart
From Sep 2024 to Oct 2024
Biopure (MM) (NASDAQ:BPUR)
Historical Stock Chart
From Oct 2023 to Oct 2024